Comparative study of Potassium Competitive acid blocker (P-CAB) and Classic proton pomp inhibitor in clinical effectiveness for gastro-esophageal reflux symptoms :Randomized Comparative study of venoprazan and esomeprazole
Not Applicable
Recruiting
- Conditions
- Patients of gastro-esophageal reflux symptoms
- Registration Number
- JPRN-UMIN000021753
- Lead Sponsor
- Hattori clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
i) The patients with warning signs such as vomiting, gastrointestinal bleeding and sudden weight loss. ii) The patients with confirmed or suspected malignant diseases. iii) The patients with a history of gastrointestinal resection of vagotomy. iv) The patients with a history of irritable bowel syndrome. v) The patients whose participation in this study would be contraindicated due to complications such as serious heaptic, renal or heart disease. vi) The Pregnant patients or possibly pregnant patients. vii) The patients prohibited the participant of this study by their attending physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The clinical improvement of GERD symptoms (heartburn, acid reflux) evaluated using self-assessment interview sheet, GerdQ, 4 weeks after treatment.
- Secondary Outcome Measures
Name Time Method i) The early efficacy of medication, on 1,3,7 day after treatment. ii) The incidence of side effects.